title: Prostate cancer: AR-V7 status in CTCs is a treatment-specific biomarker.
authors.forename: Louise
authors.initials: L
authors.lastname: Stone
mesh_terms: D059002:Androgen Receptor Antagonists / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D003430:Cross-Sectional Studies; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000097:blood* / Q000188:drug therapy* / Q000235:genetics; D020033:Protein Isoforms / Q000097:blood* / Q000235:genetics; D011944:Receptors, Androgen / Q000097:blood* / Q000235:genetics
chemical_list: C410798:AR protein, human; D059002:Androgen Receptor Antagonists; D014408:Biomarkers, Tumor; D020033:Protein Isoforms; D011944:Receptors, Androgen